Page 11 - Drug Administration For Emergency Use Authorization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug administration for emergency use authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Administration For Emergency Use Authorization Today - Breaking & Trending Today

'LIGHT AT THE END OF THE TUNNEL': Vaccinations begin in Southern Indiana


JEFFERSONVILLE — A little more than nine months after the first COVID-19 cases were identified in Indiana, vaccinations have begun at two hospitals.
Just after noon Monday, Parkview Health in Fort Wayne became the first hospital in Indiana to begin administration of the Pfizer BioNtech vaccine to frontline healthcare workers.
Clark Memorial Health in Jeffersonville followed, with its first immunizations taking place shortly after lunch Monday.
The vaccine was OK’d late last week by the U.S. Food and Drug Administration for Emergency Use Authorization.
Patients in the first tier for vaccinations were able to start signing up Saturday for an appointment, and Monday’s first 20 participants included Clark Memorial Chief Medical Officer Dr. Klaus Boel and Clark County Health Officer Dr. Eric Yazel. ....

Clark County , United States , Floyd County , New Albany , Klaus Boel , Martin Padgett , Brian Cox , Lance Ballard , Eric Yazel , Baptist Health Floyd , Drug Administration For Emergency Use Authorization , Emergency Management At Baptist Health Floyd , Clark County Health , Clark Memorial Health In Jeffersonville , Parkview Health In Fort Wayne , Parkview Health , Fort Wayne , Pfizer Biontech , Memorial Health , Drug Administration , Emergency Use , Clark Memorial Chief Medical Officer , Clark County Health Officer , Health Floyd , Washington County , Clark Memorial ,

Tulane researchers develop a rapid COVID-19 saliva test read by a smartphone device


From Tulane University
Researchers from Tulane University have developed a 15-minute COVID-19 test that is read by a smartphone to address the need to expand testing capacity in community-based settings. This test uses the same CRISPR-based approach that the researchers have submitted to the Food and Drug Administration for Emergency Use Authorization.
Rapid PCR tests typically use nasal swab samples and are performed in laboratory settings by highly trained individuals using sophisticated equipment. The saliva-based COVID-19 test, which doesn’t require lab processing, could rapidly expand testing capacity in outpatient clinics, community testing sites and other locations.
The assay developed by researchers at Tulane detects SARS-CoV-2 virus RNA in saliva to diagnose COVID-19 and is more sensitive than PCR-based tests, the current gold standard for COVID-19 diagnosis. A report describing the development and validation of this test has recently been published in t ....

Drug Administration For Emergency Use Authorization , Tulane University , Biotechnology Innovation At Tulane University , University School Of Medicine , Weatherhead Presidential Chair , Biotechnology Innovation , Drug Administration , Emergency Use , University School , துலேன் பல்கலைக்கழகம் , உயிரி தொழில்நுட்பவியல் கண்டுபிடிப்பு இல் துலேன் பல்கலைக்கழகம் , பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , வெதர்ஹெட் ப்ரெஸிடெந்ஶியல் நாற்காலி , உயிரி தொழில்நுட்பவியல் கண்டுபிடிப்பு , அவசரம் பயன்பாடு , பல்கலைக்கழகம் பள்ளி ,

Smartphone device checks spit for COVID-19


The test address the need to expand testing capacity in community-based settings
The new test uses the same CRISPR-based approach that the researchers have submitted to the Food and Drug Administration for Emergency Use Authorization.
Rapid PCR tests typically use nasal swab samples and are performed in laboratory settings by highly trained individuals using sophisticated equipment. The new saliva-based COVID-19 test, which doesn’t require lab processing, could rapidly expand testing capacity in outpatient clinics, community testing sites, and other locations.
The assay the researchers developed detects SARS-CoV-2 virus RNA in saliva to diagnose COVID-19 and is more sensitive than PCR-based tests, the current gold standard for COVID-19 diagnosis. A report describing the development and validation of the test appears in ....

Drug Administration For Emergency Use Authorization , Tulane University School Of Medicine , Drug Administration , Emergency Use , Tulane University School , துலேன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , அவசரம் பயன்பாடு , துலேன் பல்கலைக்கழகம் பள்ளி ,

Tulane researchers develop a rapid COVID-19 saliva test read by a smartphone device


 
The prototype device developed by Tulane researchers can produce COVID-19 results within 15 minutes.
Researchers from Tulane University have developed a 15-minute COVID-19 test that is read by a smartphone to address the need to expand testing capacity in community-based settings. This test uses the same CRISPR-based approach that the researchers have submitted to the Food and Drug Administration for Emergency Use Authorization.
Rapid PCR tests typically use nasal swab samples and are performed in laboratory settings by highly trained individuals using sophisticated equipment. The saliva-based COVID-19 test, which doesn t require lab processing, could rapidly expand testing capacity in outpatient clinics, community testing sites and other locations. ....

Drug Administration For Emergency Use Authorization , Tulane University , Biotechnology Innovation At Tulane University , Weatherhead Presidential Chair , Biotechnology Innovation , Drug Administration , Emergency Use , Tulane University School , துலேன் பல்கலைக்கழகம் , உயிரி தொழில்நுட்பவியல் கண்டுபிடிப்பு இல் துலேன் பல்கலைக்கழகம் , வெதர்ஹெட் ப்ரெஸிடெந்ஶியல் நாற்காலி , உயிரி தொழில்நுட்பவியல் கண்டுபிடிப்பு , அவசரம் பயன்பாடு , துலேன் பல்கலைக்கழகம் பள்ளி ,